CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving cancer treatment by using circulating tumor cells (CTCs) as a 'liquid biopsy' to tailor therapies for patients. It aims to develop a method for capturing CTCs from blood, enabling better understanding of metastasis and personalized treatment plans.
Chemotherapy is slowly being supplemented by a new generation of drugs that recognize specific targets in or on cancer cells and has proven to be more effective with markedly fewer side effects.
During the course of the disease alternative oncogenic signaling pathways take over inevitably leading to drug resistance.
As a consequence renewed tumor analysis is required to redefine the optimal treatment regiment.
However a biopsy can frequently not be obtained without risk and or discomfort to the…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Villejuif
Type: Research institute
Activity type: Research Organisations
SME: No
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
